Skip to content

BD Prefilled Normal Saline with Blunt Plastic Cannula 306518Recalls & reported problems

Becton, Dickinson And Company · NORMAL SALINE 10ML FILL IN 10ML SYR W/BP · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00382903065189), received between Jun 5, 2018 and Jun 5, 2018 — classified as 1 death.

The most frequently reported specific device problem is “Nonstandard Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Nonstandard Device1

Patient problems

  • Death1
  • Sepsis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • DeathJun 5, 2018Nonstandard Device

    IT WAS REPORTED THAT A PATIENT HAD SURGERY FOR AN ABSCESS ON (B)(6) 2018. WHILE HOSPITALIZED, THE PATIENT WAS TREATED WITH 10 ML BD¿ PRE-FILLED NORMAL SALINE SYRINGES, IN 10 ML SYRINGE WITH BD¿ BLUNT PLASTIC CANNULA. THE PATIENT WAS RELEASED AND PRESCRIBED 10 ML BD¿ PRE-FILLED NORMAL SALINE SYRINGES, IN 10 ML SYRINGE WITH BD¿ BLUNT PLASTIC CANNULA AS WELL. THE PATIENT ALSO HAD SEVERAL BLOOD AND OTHER TESTS AT THE HOSPITAL. ULTIMATELY, THE PATIENT EXPIRED FROM SEPSIS ON (B)(6) 2018. OUT OF AN ABUNDANCE OF CAUTION AND IN THE INTEREST OF PUBLIC HEALTH, BD VOLUNTARILY RECALLED CERTAIN LOTS OF BD POSIFLUSH¿ HEPARIN LOCK FLUSH AND BD¿ PRE-FILLED NORMAL SALINE FLUSH SYRINGES DUE TO A POTENTIAL FOR CONTAMINATION WITH SERRATIA MARCESCENS BACTERIUM. BD WAS NOTIFIED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND (B)(4) ABOUT A POTENTIAL EPIDEMIOLOGICAL LINK BETWEEN CATHETER RELATED BLOOD STREAM INFECTIONS AND THE S. MARCESCENS BACTERIUM. SPECIFICALLY, THE FDA AND (B)(4) IDENTIFIED A POTENTIAL CONNECTION BETWEEN REPORTS OF INFECTION IN A SMALL NUMBER OF PATIENTS CAUSED BY S. MARCESCENS ACROSS MULTIPLE STATES. (B)(4)'S INITIAL INVESTIGATION FOUND THAT AFFECTED PATIENTS HAD RECEIVED TREATMEN

    Patient problems: Death; Sepsis

    MAUDE report 7571837 ↗

Other Catheter,intravascular,therapeutic,short-term less than 30 days devices

All Catheter,intravascular,therapeutic,short-term less than 30 days devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page